Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Qiagen Webinar: Molecular Mechanisms of Neurodegeneration
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Susceptibility tensor imaging (STI) of the brain.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Keystone Symposium: T Cells: Regulation and Effector Function
Multiple Sclerosis Society Education Conference
10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Rebif approval application
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Pages